Skip to Content

Symposia on Cancer Research 2014

Illuminating Genomic Dark Matter
“ncRNA in Disease and Cancer”

October 9-10, 2014

The University of Texas MD Anderson Cancer Center
R. Lee Clark Clinic
Floor 11
1515 Holcombe Boulevard
Houston, Texas

General Information

Call for Poster Abstract Deadline is August 22, 2014.

The mission of the University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

Educational Objectives

After attending the symposium, participants should be able to:

  • Apply discoveries about the roles of small and long non-coding RNAs in cancer initiation and development to improve cancer treatments;
  • Discuss and research the complex functional networks of coding and non-coding genes and their significance to cancer;
  • Decipher the roles of non-coding RNAs as cancer biomarkers and therapeutic targets, contributing to novel drugs and treatment strategies.

Goal

It has become apparent that non-protein-coding regions of the human genome play critical roles in numerous aspects of human biology from early development to multiple diseases including cancer. MicroRNA alternations are involved in the initiation and progression of human cancer. The multiple roles of non-coding RNAs (ncRNAs) are being deciphered rapidly. In this symposium, we will highlight new fundamental and translational discoveries in this rapidly emerging field, including the use of ncRNAs in cancer detection, initiation, biology, and therapeutics. This will be accomplished by convening scientists, clinicians, and trainees to share their insights and by fostering interdisciplinary interactions. Keynote speakers are Carlo M. Croce, MD (Ohio State University James Cancer Hospital) and Jeffrey M. Rosen, PhD (Baylor College of Medicine). In addition, John S. Mattick, PhD (Garvan Institute of Medical Research) will receive the Ernst W. Bertner Memorial Award and Frank Slack, PhD (Yale University) will receive the Heath Memorial Award. There will also be a poster session for participants to represent their findings. The symposium begins Thursday morning and will end Friday afternoon.

Target Audience

The program will be of broad interest to scientists, scientists-in-training, physicians, physicians-in-training, students, nurses, and fellows interested in hearing the newest advances in the area of genomic medicine.

Educational Methods

  • Lectures
  • Question-and-Answer Sessions
  • Panel Discussions
  • Posters

© 2014 The University of Texas MD Anderson Cancer Center